Page last updated: 2024-08-16

thalidomide and cimadronate

thalidomide has been researched along with cimadronate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashihara, E; Fuchida, S; Hatsuse, M; Ochiai, N; Okamoto, M; Okano, A; Shimazaki, C; Uchida, R; Yamada, N	1

Trials

1 trial(s) available for thalidomide and cimadronate

Article	Year
Combination therapy with thalidomide, incadronate, and dexamethasone for relapsed or refractory multiple myeloma. International journal of hematology, 2005, Volume: 82, Issue:3 Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Dexamethasone; Diphosphonates; Disease-Free Survival; Female; Humans; Male; Middle Aged; Multiple Myeloma; Osteolysis; Recurrence; Thalidomide	2005

Article

Year

Combination therapy with thalidomide, incadronate, and dexamethasone for relapsed or refractory multiple myeloma.

International journal of hematology, 2005, Volume: 82, Issue:3

Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Dexamethasone; Diphosphonates; Disease-Free Survival; Female; Humans; Male; Middle Aged; Multiple Myeloma; Osteolysis; Recurrence; Thalidomide

2005